Fear Mongering At The FDA
I haven’t seen the preliminary Naproxyn data that the FDA based its press release on, but this article suggests that the increase in cardiac events wasn’t even statistically significant:
In the Alzheimer’s study, though, there was no increase in heart risk for long-term Celebrex users. There was a slight increase in heart risk for naproxen users, but the increase was so small that it may have been a chance occurrence. It was not the kind of data on which decisions involving many thousands of patients should have been made.
Related posts:
- Avandia, MI, and cardiac death
- Avandia: The RECORD study
- Obesity and heart attacks
- Avandia and heart attacks
- Asian-white couples and pregnancy
- Number needed to treat: Time to let the secret out
- Does Avandia cause heart attacks, and why the RECORD study is important
KevinMD.com on Facebook
{ 1 comment }
I just wanted to thank you for your input. More people need to come forward and support this medication. There are those of us out here who have had no negative side effects and the quality of our lives benefit from it. Without it, some of us would be practically invalids from the pain or on medications with more and worse side effects.
Comments on this entry are closed.